Welcome!

News Feed Item

Biomarkers Market - Discovery Technologies , Validation Services, Applications & Diseases - Global Trends & Forecasts to 2018

DUBLIN, April 16, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/btrshd/biomarkers_market) has announced the addition of the "Biomarkers Market - Discovery Technologies , Validation Services, Applications & Diseases - Global Trends & Forecasts to 2018" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


Biomarkers comprise definite cells, genes, molecules, gene products, enzymes, or hormones which are objectively measured as an indicator of typical biological processes, pathogenic processes, or pharmacologic response to a therapeutic intrusion. Major application areas of biomarkers are early disease diagnosis and prevention, drug target recognition, and drug discovery and development. The global market showcases high growth potential in the near future. This market is expected to grow at a CAGR of 18.5% from 2013 to 2018, to reach $40.8 billion by 2018.

The global market has been segmented into biomarker discovery technologies, biomarker services, applications, and disease indications. The biomarker discovery technologies are classified as omics technology, imaging technology, and bioinformatics. Omics technology, which includes proteomics, genomics, transcriptomics, and metabolomics, accounts for the largest share of the biomarker discovery technology market. The biomarkers services market is classified into sample preparation, assay development, and biomarker validation and testing services. Biomarker applications market has been segmented as drug discovery and development, molecular diagnostics, and personalized medicine. Based on type of diseases, the biomarker disease indication market has been classified as oncology, cardiology, neurology, and other diseases (HIV, renal disorders, diabetes, arthritis, and tuberculosis).

Globally, the biomarkers market is witnessing a transformation and is expected to grow at a high growth rate in the coming years. The growth in the market will be primarily driven by advancements in discovery technologies, government initiatives and grants for biomarker research activities, and rising demand for personalized medicine. The incidence and prevalence of chronic diseases such as cancer, cardiac diseases, and diabetes is increasing globally and hence, it is crucial to develop new preventive and diagnostics treatments. Since, biomarkers play a significant role in development of preventive and diagnostic tests and drugs, the demand of biomarkers is expected to increase rapidly.

Over the past few years, the biomarkers industry has been witnessing increasing number of contracts and partnership agreements among market players for the development of novel biomarkers. Major research on biomarkers is taking place in the field of oncology. Recent developments of companies such as Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Netherlands), Roche Diagnostics (Switzerland), Hologic, Inc. (U.S.), and Johnson & Johnson (U.S.) have exhibited inclination towards agreements and partnerships, in accordance to their key strategy to expand their market share and geographical presence.


Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Global Biomarkers Market, By Discovery Technologies

5 Services Market Of Biomarkers

6 Biomarkers Application Market

7 Biomarkers Indication Market

8 Geographical Analysis

9 Competitive Landscape

10 Company Profiles


Companies Mentioned: 

  • Abbott Laboratories
  • Abcodia Ltd
  • Affymetrix Inc
  • Agilent Technologies Inc
  • Amgen Inc
  • Astrazeneca Plc
  • Augurex Life Sciences Corp
  • Aushon Biosystems Inc
  • BGI
  • Bayer Ag
  • Beckman Coulter Inc
  • Biocrates Life Sciences AG
  • Biomarkers Strategies
  • Biosystems International
  • Bristol-Myers Squibb
  • Caprion Proteomics Inc
  • Crescendo Bioscience
  • Eisai Co Ltd
  • Epiontis GMBH
  • Epistem Holdings PLC
  • Eurogentec SA
  • Evotec AG
  • Glaxosmithkline PLC
  • Ipsen
  • Johnson & Johnson
  • Merck & Co
  • Micromedic Technologies Ltd
  • Myriad Genetics Inc
  • Nextgen Sciences Inc
  • Novartis International AG
  • Ocimum Biosolutions Ltd
  • Pacific Biomarkers Inc
  • Pfizer Inc
  • Pronota NV
  • Proteome Sciences Plc
  • Qiagen Nv
  • Quintiles Transnational Corporation
  • Roche Diagnostics Limited
  • Sanofi-Aventis
  • Siemens Healthcare
  • Trans-Hit Biomarkers Inc
  • Vermillion Inc



For more information visit http://www.researchandmarkets.com/research/btrshd/biomarkers_market


Media Contact: Laura Wood , +353-1-481-1716, [email protected]


SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
With more than 30 Kubernetes solutions in the marketplace, it's tempting to think Kubernetes and the vendor ecosystem has solved the problem of operationalizing containers at scale or of automatically managing the elasticity of the underlying infrastructure that these solutions need to be truly scalable. Far from it. There are at least six major pain points that companies experience when they try to deploy and run Kubernetes in their complex environments. In this presentation, the speaker will d...
Discussions of cloud computing have evolved in recent years from a focus on specific types of cloud, to a world of hybrid cloud, and to a world dominated by the APIs that make today's multi-cloud environments and hybrid clouds possible. In this Power Panel at 17th Cloud Expo, moderated by Conference Chair Roger Strukhoff, panelists addressed the importance of customers being able to use the specific technologies they need, through environments and ecosystems that expose their APIs to make true ...
"Space Monkey by Vivent Smart Home is a product that is a distributed cloud-based edge storage network. Vivent Smart Home, our parent company, is a smart home provider that places a lot of hard drives across homes in North America," explained JT Olds, Director of Engineering, and Brandon Crowfeather, Product Manager, at Vivint Smart Home, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
We are seeing a major migration of enterprises applications to the cloud. As cloud and business use of real time applications accelerate, legacy networks are no longer able to architecturally support cloud adoption and deliver the performance and security required by highly distributed enterprises. These outdated solutions have become more costly and complicated to implement, install, manage, and maintain.SD-WAN offers unlimited capabilities for accessing the benefits of the cloud and Internet. ...
Business professionals no longer wonder if they'll migrate to the cloud; it's now a matter of when. The cloud environment has proved to be a major force in transitioning to an agile business model that enables quick decisions and fast implementation that solidify customer relationships. And when the cloud is combined with the power of cognitive computing, it drives innovation and transformation that achieves astounding competitive advantage.
In an era of historic innovation fueled by unprecedented access to data and technology, the low cost and risk of entering new markets has leveled the playing field for business. Today, any ambitious innovator can easily introduce a new application or product that can reinvent business models and transform the client experience. In their Day 2 Keynote at 19th Cloud Expo, Mercer Rowe, IBM Vice President of Strategic Alliances, and Raejeanne Skillern, Intel Vice President of Data Center Group and G...
DXWorldEXPO LLC announced today that "IoT Now" was named media sponsor of CloudEXPO | DXWorldEXPO 2018 New York, which will take place on November 11-13, 2018 in New York City, NY. IoT Now explores the evolving opportunities and challenges facing CSPs, and it passes on some lessons learned from those who have taken the first steps in next-gen IoT services.
The current age of digital transformation means that IT organizations must adapt their toolset to cover all digital experiences, beyond just the end users’. Today’s businesses can no longer focus solely on the digital interactions they manage with employees or customers; they must now contend with non-traditional factors. Whether it's the power of brand to make or break a company, the need to monitor across all locations 24/7, or the ability to proactively resolve issues, companies must adapt to...
"IBM is really all in on blockchain. We take a look at sort of the history of blockchain ledger technologies. It started out with bitcoin, Ethereum, and IBM evaluated these particular blockchain technologies and found they were anonymous and permissionless and that many companies were looking for permissioned blockchain," stated René Bostic, Technical VP of the IBM Cloud Unit in North America, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventi...
In this presentation, you will learn first hand what works and what doesn't while architecting and deploying OpenStack. Some of the topics will include:- best practices for creating repeatable deployments of OpenStack- multi-site considerations- how to customize OpenStack to integrate with your existing systems and security best practices.
"DevOps is set to be one of the most profound disruptions to hit IT in decades," said Andi Mann. "It is a natural extension of cloud computing, and I have seen both firsthand and in independent research the fantastic results DevOps delivers. So I am excited to help the great team at @DevOpsSUMMIT and CloudEXPO tell the world how they can leverage this emerging disruptive trend."
You want to start your DevOps journey but where do you begin? Do you say DevOps loudly 5 times while looking in the mirror and it suddenly appears? Do you hire someone? Do you upskill your existing team? Here are some tips to help support your DevOps transformation. Conor Delanbanque has been involved with building & scaling teams in the DevOps space globally. He is the Head of DevOps Practice at MThree Consulting, a global technology consultancy. Conor founded the Future of DevOps Thought Leade...
Everyone wants the rainbow - reduced IT costs, scalability, continuity, flexibility, manageability, and innovation. But in order to get to that collaboration rainbow, you need the cloud! In this presentation, we'll cover three areas: First - the rainbow of benefits from cloud collaboration. There are many different reasons why more and more companies and institutions are moving to the cloud. Benefits include: cost savings (reducing on-prem infrastructure, reducing data center foot print, redu...
Founded in 2000, Chetu Inc. is a global provider of customized software development solutions and IT staff augmentation services for software technology providers. By providing clients with unparalleled niche technology expertise and industry experience, Chetu has become the premiere long-term, back-end software development partner for start-ups, SMBs, and Fortune 500 companies. Chetu is headquartered in Plantation, Florida, with thirteen offices throughout the U.S. and abroad.
René Bostic is the Technical VP of the IBM Cloud Unit in North America. Enjoying her career with IBM during the modern millennial technological era, she is an expert in cloud computing, DevOps and emerging cloud technologies such as Blockchain. Her strengths and core competencies include a proven record of accomplishments in consensus building at all levels to assess, plan, and implement enterprise and cloud computing solutions. René is a member of the Society of Women Engineers (SWE) and a m...